Pharma Focus Asia

Pharma Press Releases

Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.

Fujirebio and Sysmex Expand Cdmo Partnership Into the Field of Neurodegenerative Diseases Under Their Immunoassay Collaboration

Thursday, November 30, 2023

Fujirebio Holdings Inc and Sysmex Corporation today announced that they have entered into an agreement to expand their Contract Development and Manufacturing Organization

NurExone Biologic Extends Spinal Cord Injury Therapy Portfolio With New RNA Sequences Promoting Healing and Regeneration

Thursday, November 30, 2023

NurExone Biologic Inc has recently unveiled laboratory tests of its secondary two proprietary sequences representing a significant advancement in the treatment of spinal cord injuries

Polaris Group Announces First Patient Successfully Dosed with ADI-PEG 20/Placebo in Phase 2a Non-Alcoholic Steatohepatitis (NASH) Study

Thursday, November 30, 2023

Polaris Group today announced that the first patient was successfully dosed in the Phase a clinical study for NonAlcoholic Steatohepatitis

Medavail Announces Agreement With New Orleans-based St. Thomas Community Health Centers for Deployment of Two M4 Medcenters

Wednesday, November 29, 2023

MedAvail Holdings Inc an innovative pharmacy technology company announced today that it has entered into an agreement with New Orleansbased St Thomas Community Health

Akeso Launches Construction of Shanghai Global R&D Center to Accelerate Its Innovation Globalization Strategy

Wednesday, November 29, 2023

Akeso Shanghai Global RD Center was successfully held at the Zhangjiang headquarters park in Shanghai The establishment of the Akeso Global RD Center

Neumora Therapeutics Announces NMRA-266 IND Clearance and Initiation of Phase 1 Clinical Study

Tuesday, November 28, 2023

Neumora Therapeutics Inc a clinicalstage biopharmaceutical company redefining neuroscience drug development today announced the initiation of a Phase single ascending dose multiple ascending dose study evaluating NMRA

Lexaria's Technology Improves the Oral Performance of the Rybelsus(R)-Branded GLP-1 drug Semaglutide in Human Pilot Study

Monday, November 27, 2023

Lexaria Bioscience Corp the Company or Lexaria a global innovator in drug delivery platforms announces positive interim results from a human pilot study currently underway

Everest Medicines Announces China NMPA's Approval of NefeconĀ® for the Treatment of Primary IgA Nephropathy in Adult Patients

Friday, November 24, 2023

Everest Medicines a biopharmaceutical company focused on the development manufacturing and commercialization of innovative medicines and vaccines announced today that Chinas

Innovent and AnHeart's Taletrectinib NDA Accepted by China's NMPA

Friday, November 24, 2023

Innovent Biologics Inc a worldclass biopharmaceutical company that develops manufactures and commercializes high quality medicines for the treatment of oncology metabolic autoimmune ophthalmology and other major diseases

WuXi Biologics Successfully Implemented a Fully Integrated Continuous Process with a Breakthrough Productivity of ~6 g/L/day at Pilot Scale

Thursday, November 23, 2023

WuXi Biologics a leading global Contract Research Development and Manufacturing Organization CRDMO announced today that it has accomplished endtoend DS manufacturing at pilot scale utilizing WuXiUPTM